Snapdragon Chemistry today announced that the previously announced acquisition by Asymchem will not proceed. Snapdragon and Asymchem were unable to agree to mitigation terms that would satisfy the U.S. Treasury’s Committee on Foreign Investment in the United States (CFIUS).
The news comes at a time of substantial growth for Snapdragon. Snapdragon recently commissioned a new, 51,000 square foot R&D and GMP manufacturing facility.
